Current and historical daily PE Ratio for XVIPF (
Xvivo Perfusion AB
) from 2014 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Xvivo Perfusion AB stock (XVIPF) PE ratio as of Jun 09 2024 is 134.66.
More Details
Xvivo Perfusion AB (XVIPF) PE Ratio (TTM) Chart
Xvivo Perfusion AB (XVIPF) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1244
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Xvivo Perfusion AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 134.7 | 2024-04-05 | 82.4 |
| 2024-06-07 | 134.7 | 2024-04-04 | 82.4 |
| 2024-06-06 | 130.5 | 2024-04-03 | 82.4 |
| 2024-06-05 | 130.5 | 2024-04-02 | 82.4 |
| 2024-06-04 | 130.5 | 2024-04-01 | 82.4 |
| 2024-06-03 | 130.5 | 2024-03-28 | 81.5 |
| 2024-05-31 | 130.5 | 2024-03-27 | 87.9 |
| 2024-05-30 | 123.0 | 2024-03-26 | 88.8 |
| 2024-05-29 | 123.0 | 2024-03-25 | 88.8 |
| 2024-05-28 | 115.7 | 2024-03-22 | 88.8 |
| 2024-05-24 | 118.3 | 2024-03-21 | 91.1 |
| 2024-05-23 | 118.3 | 2024-03-20 | 89.1 |
| 2024-05-22 | 118.3 | 2024-03-19 | 89.1 |
| 2024-05-21 | 118.3 | 2024-03-18 | 89.1 |
| 2024-05-20 | 118.3 | 2024-03-15 | 87.5 |
| 2024-05-17 | 115.9 | 2024-03-14 | 87.5 |
| 2024-05-16 | 115.9 | 2024-03-13 | 87.5 |
| 2024-05-15 | 109.1 | 2024-03-12 | 87.5 |
| 2024-05-14 | 109.1 | 2024-03-11 | 87.5 |
| 2024-05-13 | 109.1 | 2024-03-08 | 87.5 |
| 2024-05-10 | 109.1 | 2024-03-07 | 87.5 |
| 2024-05-09 | 109.6 | 2024-03-06 | 87.5 |
| 2024-05-08 | 109.6 | 2024-03-05 | 87.5 |
| 2024-05-07 | 109.6 | 2024-03-04 | 88.3 |
| 2024-05-06 | 109.6 | 2024-03-01 | 88.3 |
| 2024-05-03 | 106.3 | 2024-02-29 | 88.3 |
| 2024-05-02 | 106.3 | 2024-02-28 | 85.4 |
| 2024-05-01 | 100.6 | 2024-02-27 | 85.4 |
| 2024-04-30 | 100.6 | 2024-02-26 | 86.6 |
| 2024-04-29 | 100.6 | 2024-02-23 | 93.3 |
| 2024-04-26 | 100.6 | 2024-02-22 | 93.3 |
| 2024-04-25 | 100.6 | 2024-02-21 | 93.3 |
| 2024-04-24 | 104.8 | 2024-02-20 | 93.3 |
| 2024-04-23 | 92.1 | 2024-02-16 | 93.3 |
| 2024-04-22 | 92.2 | 2024-02-15 | 93.3 |
| 2024-04-19 | 92.2 | 2024-02-14 | 93.3 |
| 2024-04-18 | 94.2 | 2024-02-13 | 93.3 |
| 2024-04-17 | 94.2 | 2024-02-12 | 93.3 |
| 2024-04-16 | 94.2 | 2024-02-09 | 93.3 |
| 2024-04-15 | 94.2 | 2024-02-08 | 93.3 |
| 2024-04-12 | 94.2 | 2024-02-07 | 93.3 |
| 2024-04-11 | 82.4 | 2024-02-06 | 93.3 |
| 2024-04-10 | 82.4 | 2024-02-05 | 93.3 |
| 2024-04-09 | 82.4 | 2024-02-02 | 93.3 |
| 2024-04-08 | 82.4 | 2024-02-01 | 93.3 |
Xvivo Perfusion AB (XVIPF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Xvivo Perfusion AB
NAICS : 334517
SIC : 3842
ISIN : SE0004840718
Compare
Compare
Traded in other countries / regions
XVIVO.Sweden0RKL.UKXVIPF.USA3XV.Germany IPO Date
2014-02-05Description
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers